Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Threshold Pharmaceuticals Inc (NASDAQ:THLD)

0.574
Delayed Data
As of Mar 27
 +0.0062 / +1.09%
Today’s Change
0.30
Today|||52-Week Range
1.48
+30.16%
Year-to-Date
No recent news for Threshold Pharmaceuticals Inc.

Today’s Trading

Previous close0.57
Today’s open0.57
Day’s range0.54 - 0.58
Volume523,129
Average volume (3 months)1,103,887
Market cap$41.1M
Dividend yield--
Data as of 03/27/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-164.81%
Earnings growth (next 5 years)--
Revenue growth (last year)+422.45%
P/E ratio0.9
Price/Sales0.46
Price/Book1.00

Competitors

 Today’s
change
Today’s
% change
PTXPernix Therapeutics ...+0.20+5.04%
DMPIDelMar Pharmaceutica...+0.03+0.75%
CHMAChiasma Inc+0.15+9.37%
TPIVTapImmune Inc+0.01+0.22%
Data as of 03/27/2017

Financials

Last reporting dateMarch 28, 2017
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$76.9M
Annual profit (last year)$43.8M
Net profit margin56.97%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Harold E. Selick
Vice President-
Clinical Operations
Kristen Quigley
Corporate headquarters
South San Francisco, California

Forecasts


Search for Jobs